RNS Number : 3633P
Ilika plc
22 May 2024
 

Ilika plc

("Ilika" or the "Company")

 

Key Goliath Technology Validation Milestone

 

Ilika commences customer-sponsored validation of first release of prototype Goliath battery

 

Ilika (AIM: IKA), an independent global expert in solid-state battery technology, announces it has commenced testing of its initial batch of P1 Goliath electric vehicle ("EV") prototype batteries in a customer-sponsored programme. This follows the successful completion of production and in-house testing.

 

In November 2023, Ilika announced it had achieved its D4 development point, which is a design-freeze milestone in its Goliath roadmap upon which Ilika's first prototype for customer release, P1, is based. The P1 prototype is an intermediate milestone on Ilika's roadmap to its minimum viable product ("MVP") expected in 2025. The P1 prototype is a solid-state pouch cell with an NMC cathode and a silicon anode.

 

In line with the timeframe outlined in the last annual results published in July 2023, Ilika confirms that it has successfully manufactured and tested batches of P1 pouch cells based on the D4 development point and has now commenced a customer-designed and sponsored test programme in the first of a series of commercial engagements with automotive OEMs and Tier 1 companies.

 

Work continues on Ilika's roadmap through to MVP in calendar year 2025. Ilika's Goliath MVP, or P2 prototypes, will underpin licensing opportunities. Further detail regarding the product curve and development points can be found on page 11 of the Company's 2023 Annual Report, which is available by clicking here.

 

Graeme Purdy, Ilika CEO, stated: "Ilika has successfully delivered another milestone on its Goliath roadmap. We are delighted to be engaging with a portfolio of interested OEMs and Tier 1 companies on commercially sponsored evaluation programmes.

 

"We continue to progress towards commercialisation as planned and remain on track to demonstrate our Goliath technology at pilot scale to  underpin licensing discussions and technology transfer. Our near-term focus is on increasing battery testing capacity and upgrading our dry rooms, with development strongly aligned to the market growth and structural drivers within the EV sector."

 

For more information contact:

 


Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Jason Stewart, Chief Financial Officer








Liberum Capital Limited (Nomad and Joint Broker)

Tel: 020 3100 2000

Andrew Godber, John More


Nikhil Varghese, Joshua Borlant






Joh. Berenberg, Gossler & Co. KG (Joint Broker)

Tel: 020 3207 8700

Mark Whitmore, Detlir Elezi, Natasha Ninkov








Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Nick Rome, Charlotte Edgar, Joe Walker


 





About Ilika plc - https://www.ilika.com

Ilika specialises in the developing and commercialisation of solid state batteries. The Company's mission is to rapidly develop leading-edge IP, manufacture and license solid state batteries for markets that cannot be addressed with conventional batteries due to their safety, charge rates, energy density and life limits. The Company achieves this by using ceramic-based lithium-ion technology that is inherently safe in manufacture and usage, higher thermal tolerance and easier to recycle which differentiates our products from existing batteries.

 

The Company has two product lines. Its Stereax batteries which are designed for powering miniature medical implants, industrial wireless sensors and specialist internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEWFWFELSESI